Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
antitrust, atherectomy, BioCardia, Biodegradable, Biotech, Blue, challenging, Columbia, composition, conjunction, consequential, declaratory, disposal, Eastern, Edge, eligible, entry, explore, factually, Fiber, formal, guarantee, HMO, House, indemnify, Inline, inventorship, Janssen, Johnson, Korean, largest, liver, Louisiana, MDD, MDR, medicine, merger, midnight, Minister, misappropriation, neutral, nonrecurring, notification, notified, omit, overexposure, ownership, Page, pharmaceutical, prejudice, Prime, read, retention, Scimed, scope, secret, Securityholder, Sherman, Shield, specialty, sponsored, stream, superficial, Synergy, Taiwan, tangible, tender, tendered, tentative, thereon, therewith, turnover, unallocated, unrestricted, UT, validly, vein, Western, won, zytiga
Removed:
cord, delivered, disclosing, finalized, flat, SCS, Spectra, Stimulator, volume, WaveWriter
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view